1. Home
  2. VRNA vs PYCR Comparison

VRNA vs PYCR Comparison

Compare VRNA & PYCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VRNA
  • PYCR
  • Stock Information
  • Founded
  • VRNA 2005
  • PYCR 1990
  • Country
  • VRNA United Kingdom
  • PYCR United States
  • Employees
  • VRNA N/A
  • PYCR N/A
  • Industry
  • VRNA Biotechnology: Pharmaceutical Preparations
  • PYCR Computer Software: Prepackaged Software
  • Sector
  • VRNA Health Care
  • PYCR Technology
  • Exchange
  • VRNA Nasdaq
  • PYCR Nasdaq
  • Market Cap
  • VRNA 2.2B
  • PYCR 2.6B
  • IPO Year
  • VRNA 2017
  • PYCR 2021
  • Fundamental
  • Price
  • VRNA $35.66
  • PYCR $16.40
  • Analyst Decision
  • VRNA Strong Buy
  • PYCR Buy
  • Analyst Count
  • VRNA 6
  • PYCR 16
  • Target Price
  • VRNA $43.83
  • PYCR $19.50
  • AVG Volume (30 Days)
  • VRNA 1.1M
  • PYCR 932.7K
  • Earning Date
  • VRNA 11-04-2024
  • PYCR 11-06-2024
  • Dividend Yield
  • VRNA N/A
  • PYCR N/A
  • EPS Growth
  • VRNA N/A
  • PYCR N/A
  • EPS
  • VRNA N/A
  • PYCR N/A
  • Revenue
  • VRNA $5,624,000.00
  • PYCR $678,836,000.00
  • Revenue This Year
  • VRNA N/A
  • PYCR $13.67
  • Revenue Next Year
  • VRNA $554.09
  • PYCR $11.60
  • P/E Ratio
  • VRNA N/A
  • PYCR N/A
  • Revenue Growth
  • VRNA 1127.95
  • PYCR 17.45
  • 52 Week Low
  • VRNA $11.39
  • PYCR $10.92
  • 52 Week High
  • VRNA $40.13
  • PYCR $22.66
  • Technical
  • Relative Strength Index (RSI)
  • VRNA 51.76
  • PYCR 60.83
  • Support Level
  • VRNA $36.49
  • PYCR $16.51
  • Resistance Level
  • VRNA $40.13
  • PYCR $17.70
  • Average True Range (ATR)
  • VRNA 2.01
  • PYCR 0.58
  • MACD
  • VRNA -0.30
  • PYCR 0.08
  • Stochastic Oscillator
  • VRNA 47.60
  • PYCR 64.48

About VRNA Verona Pharma plc

Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.

About PYCR Paycor HCM Inc.

Paycor HCM provides payroll and human capital management solutions to small and midsize clients in the United States via a software-as-a-service model. Alongside core payroll functionality, the firm's platform offers a suite of HCM solutions including talent management and time and attendance software, third-party integration capabilities, and industry-specific configurations. The firm targets customers with 10-1,000 employees and had over 30,500 customers as of June 2024.

Share on Social Networks: